Chesapeake Urology Associates :: Overactive Bladder

(866) 953-3111

Page Options

Overactive Bladder

If you void (urinate) more than eight times per day, you may be eligible to participate in this research study.

A Phase IIb Randomized, Placebo and Active Comparator-Controlled, 2 Part Clinical Trial to Study the Efficacy and Safety of MK-4618 in Women with Overactive Bladder.

Research Location:
Glen Burnie/Landmark
806 Landmark Drive, Suite 118
Glen Burnie, MD 21061
410-760-9400
Contact Virginia Michaels, vmichaels@cua.md or 443.471.5753

For additional information go to: http://clinicaltrials.gov/ct2/show/NCT01314872?term=overactive+bladder+merck&rank=4

A 12-week, randomized, double-blind, placebo-controlled, parallel-group, multicenter trial to evaluate the efficacy and safety of Fesoterodine flexible dose regimen in vulnerable elderly patients with overactive bladder.

For additional information go to: www.pfizer.com

Research Locations:
Glen Burnie, MD
806 Landmark Dr., Suite 118
Glen Burnie, MD 21061
Contact Virginia Michaels, vmichaels@cua.md or 410-760-9400

Towson, MD
8322 Bellona Ave., Suite 202
Towson, MD 21204
Contact Debi Robertson, drobertson@cua.md or 410-825-6310 x163

« Current Clinical Trials

Erectile Dysfunction (ED)

Enlarged Prostate: (Benign Prostatic Hyperplasia/BPH)

Peyronies

Kidney Stones

Bladder Cancer

Prostate Cancer

Overactive Bladder